Rheumatology experts convened an international committee to handle the nagging issue directly.

Dr. Lockshin can be among the executive committee people of APS ACTION. Dr. Lockshin heads a subcommittee tasked with exploring funding choices for keeping the infrastructure of the international consortium and developing a comprehensive individual registry. ‘APS Actions hit the ground running, and you want to continue this enthusiasm by shifting forward on all APS research-related issues. Associates of APS ACTION are dedicated to standardizing clinical research and treatment and developing evidence-based treatment recommendations, improving patient outcomes ultimately.’.. Continue reading